Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00723112 · ClinicalTrials.gov registry record

The Role of Erythropoietin in Myelodysplastic Syndrome

A clinical trial, sponsored by University of Utah.

Completed
Registry status
8
Enrollment target

NCT00723112: Completed study, sponsored by University of Utah.

NCT00723112 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00723112 has completed, sponsored by University of Utah.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

The purpose of the study is to elucidate the causative molecular events responsible for the abnormal erythropoiesis in MDS.

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2007-02
Est. Completion 2010-10
University of Utah

818 total trials

What the finished NCT00723112 record still lists

NCT00723112 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00723112 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00723112 about?

NCT00723112 is a clinical study titled "The Role of Erythropoietin in Myelodysplastic Syndrome". The purpose of the study is to elucidate the causative molecular events responsible for the abnormal erythropoiesis in MDS.

What is the current status of trial NCT00723112?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2007-02. Estimated completion is 2010-10.

Who is sponsoring clinical trial NCT00723112?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00723112, the US trial registry maintained by the National Library of Medicine. NCT00723112 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.